OUR PRODUCTS

MOBILE APPS

GENERAL INFO

VRDN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Viridian Therapeutics (VRDN) Earnings Date & Reports

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VRDN is expected to report earnings to -100 cents per share on November 18

Viridian Therapeutics VRDN Stock Earnings Reports

Q3'25

Est.

$-1.01

Q2'25

Est.

$-1.00

Q1'25

Beat

by $0.11

Q4'24

Beat

by $0.22

Q3'24

Missed

by $0.09

The last earnings report on August 06 showed earnings per share of -100 cents, meeting the estimate of -100 cents. With 668.82K shares outstanding, the current market capitalization sits at 1.47B.

View a ticker or compare two or three

Compare

VRDN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VRDN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRDN showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

221 Crescent Street

Phone

+1 617 272-4600

Employees

Web

https://www.viridiantherapeutics.com